Literature DB >> 6414612

Synthesis of intrathecal interferon in systemic lupus erythematosus with neurological complications.

P Lebon, G R Lenoir, A Fischer, A Lagrue.   

Abstract

Intrathecal synthesis of interferon in the absence of viral or bacterial infection was detected during the occurrence of neurological complications in two patients with systemic lupus erythematosus. The interferons displayed characteristics similar to those observed in the sera of patients with the disease. No interferon inducing activity was detected in the cerebrospinal fluid or serum of the two patients. These observations support the hypothesis of a localised mechanism of interferon induction in systemic lupus erythematosus which includes the interaction of lymphocytes with damaged tissues.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6414612      PMCID: PMC1549458          DOI: 10.1136/bmj.287.6400.1165

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  20 in total

1.  Interferon assays and quantitative virus determinations in a fatal infection in man with western equine encephalomyelitis virus.

Authors:  J P Luby; C V Sanders; S E Sulkin
Journal:  Am J Trop Med Hyg       Date:  1971-09       Impact factor: 2.345

2.  The effect of exogenous interferon: acceleration of autoimmune and renal diseases in (NZB/W) F1 mice.

Authors:  C Adam; Y Thoua; P Ronco; P Verroust; M Tovey; L Morel-Maroger
Journal:  Clin Exp Immunol       Date:  1980-05       Impact factor: 4.330

3.  Different mechanisms for alpha and beta interferon induction.

Authors:  P Lebon; M J Commoy-Chevalier; B Robert-Galliot; C Chany
Journal:  Virology       Date:  1982-06       Impact factor: 3.616

4.  Multiple interferons in the circulation of patients with systemic lupus erythematosus and vasculitis.

Authors:  J J Hooks; G W Jordan; T Cupps; H M Moutsopoulos; A S Fauci; A L Notkins
Journal:  Arthritis Rheum       Date:  1982-04

5.  [Identification of lymphocyte populations producing alpha-interferon by monoclonal antibodies].

Authors:  P Lebon; A Bernard; L Boumsell
Journal:  C R Seances Acad Sci III       Date:  1982-09-20

6.  [Herpes encephalitis in adults and interferon (author's transl)].

Authors:  F Vezinet; P Lebon; C Amoudry; C Gibert
Journal:  Nouv Presse Med       Date:  1981-03-28

7.  Serum interferon levels in patients with systemic lupus erythematosus.

Authors:  S R Ytterberg; T J Schnitzer
Journal:  Arthritis Rheum       Date:  1982-04

8.  Interferon production of vitro by leucocytes from patients with systemic lupus erythematosus and rheumatoid arthritis.

Authors:  P A Neighbour; A I Grayzel
Journal:  Clin Exp Immunol       Date:  1981-09       Impact factor: 4.330

9.  Systemic lupus erythematosus: presence in human serum of an unusual acid-labile leukocyte interferon.

Authors:  O T Preble; R J Black; R M Friedman; J H Klippel; J Vilcek
Journal:  Science       Date:  1982-04-23       Impact factor: 47.728

10.  [Production of human type I interferon by lymphocytes in contact with cells infected by herpesvirus and fixed with glutaraldehyde].

Authors:  P Lebon; M J Commoy-Chevalier; B Robert-Galliot; A Morin; C Chany
Journal:  C R Seances Acad Sci D       Date:  1980-01-07
View more
  4 in total

Review 1.  New roles for the major human 3'-5' exonuclease TREX1 in human disease.

Authors:  David Kavanagh; Dirk Spitzer; Parul H Kothari; Aisha Shaikh; M Kathryn Liszewski; Anna Richards; John P Atkinson
Journal:  Cell Cycle       Date:  2008-06-16       Impact factor: 4.534

2.  Presence of an acid-labile alpha-interferon in sera from fetuses and children with congenital rubella.

Authors:  P Lebon; F Daffos; A Checoury; L Grangeot-Keros; F Forestier; J E Toublanc
Journal:  J Clin Microbiol       Date:  1985-05       Impact factor: 5.948

Review 3.  Controversies in lupus: nervous system involvement.

Authors:  G A Bruyn
Journal:  Ann Rheum Dis       Date:  1995-03       Impact factor: 19.103

Review 4.  Interferon pathway in SLE: one key to unlocking the mystery of the disease.

Authors:  Lars Rönnblom; Dag Leonard
Journal:  Lupus Sci Med       Date:  2019-08-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.